Vatreptacog alfa
Vatreptacog alfa is a recombinant hFVIIa analog, differing from native FVIIa by three amino acid substitutions (V158D, E296V and M298Q) in the protease domain. Vatreptacog alfa exhibits enhanced tissue factor-independent enzymatic activity toward activated platelets. Vatreptacog alfa can be used in the research of hemophilia.
For research use only. We do not sell to patients.
- CAS No.: 897936-89-9
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
Human
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
Product Image
ELISA, FACS, Functional assay
Chemical Information
-
CAS No. 897936-89-9
-
SMILES
[Vatreptacog alfa]
-
Synonyms
NN-1731
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Vatreptacog alfa Related Classifications
HY-P992152 Related Classifications
Powered by Bioz
- Vatreptacog alfa
- 897936-89-9
- NN-1731
- NN1731
- NN 1731
- Factor VIIa
- Drug Derivative
- tissue factor
- human factor VII knock-in transgenic mice
- immunoglobulin M subtype
- immunoglobulin G subtype
- neonatal recombinant factor VIIa-tolerized rats
- protease domain
- hemophilia a
- recombinant human factor VII
- hemophilia b
- activated platelets
- Inhibitor
- inhibitor
- inhibit